Yudong Qiu

321 Zhongshan Road
Nanjing, 210008, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Preoperative prediction of pancreatic neuroendocrine tumors grade based on computed tomography, magnetic resonance imaging and endoscopic ultrasonography.

Preoperative prediction of pancreatic neuroendocrine tumors grade based on computed tomography, magnetic resonance imaging and endoscopic ultrasonography.

Journal: Abdominal radiology (New York)

Published: December 18, 2024

Prediction model for lymph node metastasis in the right lateral region of papillary thyroid carcinoma.

Prediction model for lymph node metastasis in the right lateral region of papillary thyroid carcinoma.

Journal: Endocrine

Published: August 02, 2024

Loss of Claudin-1 incurred by DNMT aberration promotes pancreatic cancer progression.

Loss of Claudin-1 incurred by DNMT aberration promotes pancreatic cancer progression.

Journal: Cancer letters

Published: October 10, 2023

PD-1 blockade plus chemoradiotherapy as preoperative therapy for patients with BRPC/LAPC: A biomolecular exploratory, phase II trial.

PD-1 blockade plus chemoradiotherapy as preoperative therapy for patients with BRPC/LAPC: A biomolecular exploratory, phase II trial.

Journal: Cell reports. Medicine

Published: October 24, 2022

Lipid incorporated synthetic hydrogels show cartilage-like lubrication.

Lipid incorporated synthetic hydrogels show cartilage-like lubrication.

Journal: Science bulletin

Published: March 15, 2021

Corrigendum to "PP2Acα inhibits PFKFB2-induced glycolysis to promote termination of liver regeneration" [Biochem. Biophys. Res. Commun. 526 (1) (2020 May 21) 1-7].

Corrigendum to "PP2Acα inhibits PFKFB2-induced glycolysis to promote termination of liver regeneration" [Biochem. Biophys. Res. Commun. 526 (1) (2020 May 21) 1-7].

Journal: Biochemical and biophysical research communications

Published: August 11, 2020

PP2Acα inhibits PFKFB2-induced glycolysis to promote termination of liver regeneration.

PP2Acα inhibits PFKFB2-induced glycolysis to promote termination of liver regeneration.

Journal: Biochemical and biophysical research communications

Published: February 18, 2020

Typing FGFR2 translocation determines the response to targeted therapy of intrahepatic cholangiocarcinomas.

Typing FGFR2 translocation determines the response to targeted therapy of intrahepatic cholangiocarcinomas.

Journal: Cell death & disease

Published: November 07, 2019

LRRK2 Is Associated with Recurrence-Free Survival in Intrahepatic Cholangiocarcinoma and Downregulation of LRRK2 Suppresses Tumor Progress In Vitro.

LRRK2 Is Associated with Recurrence-Free Survival in Intrahepatic Cholangiocarcinoma and Downregulation of LRRK2 Suppresses Tumor Progress In Vitro.

Journal: Digestive diseases and sciences

Published: April 25, 2019

Predicting IDH mutation status of intrahepatic cholangiocarcinomas based on contrast-enhanced CT features.

Predicting IDH mutation status of intrahepatic cholangiocarcinomas based on contrast-enhanced CT features.

Journal: European radiology

Published: January 15, 2017

Development and validation of a novel predictive scoring model for microvascular invasion in patients with hepatocellular carcinoma.

Development and validation of a novel predictive scoring model for microvascular invasion in patients with hepatocellular carcinoma.

Journal: European journal of radiology

Published: October 15, 2016

Mutation Detection of Fibroblast Growth Factor Receptor 3 for Infiltrative Hepatocellular Carcinoma by Whole-Exome Sequencing.

Mutation Detection of Fibroblast Growth Factor Receptor 3 for Infiltrative Hepatocellular Carcinoma by Whole-Exome Sequencing.

Journal: Digestive diseases and sciences

Published: July 31, 2016

Showing 1-12 of 14

Last Updated: 09/26/2026